A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications

Southern Medical Journal

Volumn 100, Issue 11, 2007, Pages 1085-1090

  DiPalma, Jack A ^a   Cleveland, Mark B ^b   McGowan, John ^b   Herrera, Jorge L ^b  

^a Gastroenterology Academic Offices   (United States)

^b NONE

Author keywords

Constipating medications; Constipation; Polyethylene glycol

Indexed keywords

CALCIUM; ELECTROLYTE; MACROGOL 3350; PLACEBO; THYROTROPIN;

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; BLOOD CHEMISTRY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DYSPEPSIA; ERUCTATION; FECES ANALYSIS; FEMALE; FLATULENCE; GAS; HEMATOLOGY; HUMAN; LABORATORY TEST; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; STOMACH DISCOMFORT; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONSTIPATION; FEMALE; HUMANS; LAXATIVES; MALE; MIDDLE AGED; PLACEBOS; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME;

EID: 35948966370     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318157ec8f     Document Type: Article

References (19)

1. PDR Electronic Library; Medical Economics Inc., release 2000.1.
2. Rogers M, Cerda JJ. Editorial: The narcotic bowel syndrome. J Clin Gasteroenterol 1989;11:132-135.
3. Crowther AGO. Management of constipation in terminally ill patients. J Intern Med Res 1978;6:348-349.
4. Rutland TJ, Adeniji OA, DiPalma JA. Prevalence of medications associated constipation (abstract 320). Am J Gastroenterol 2004;99(suppl):5103-5104.
5. Locke GR, Pemberton JH, Phillips SF. American Gastroenterological Association Medical Position Statement: Guidelines on Constipation. Gastroenterology 2000;119:1761-1766.
6. Locke GR, Pemberton JH, Phillips SF. American Gastroenterological Association: Technical Review on Constipation. Gastroenterology 2000;119:1766-1778.
7. Talley NJ. Management of chronic constipation. Rev Gastroenterol Disord 2004;4:18-24.
8. Schiller LR. Review article: the therapy of constipation. Aliment Pharmacol Ther 2001;15:749-763.
9. DiPalma JA. Current treatment options for chronic constipation. Rev Gastroenterol Disord 2004;4:S34-S42.
10. Talley NJ, Weaver AL, Zinsmeister AR, et al. Functional constipation and outlet delay: a population-based study. Gastroenterology 1993;105:781-790.
11. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol 1996;91:19-25.
12. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003;98:1107-1111.
13. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182(suppl):11S-18S.
14. Yuan CS, Foss JF, O'Connor M, et al. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 2000;283:367-372.
15. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl II):II-43-II-47.
16. DiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95:446-450.
17. Cleveland MvB, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J 2001;94:478-481.
18. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Rev Gastroenterol Disord 2004;4:S3-S10.
19. Tran LC, Di Palma JA. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation. J Clin Gastroenterol 2005;39:600-602.